Global Influenza Diagnostics Market to Grow at a CAGR of 8.56%, 2017-2021 With Alere, Becton Dickinson, bioMerieux & Quidel Dominating - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Influenza Diagnostics Market 2017-2021" report to their offering.

The global influenza diagnostics market to grow at a CAGR of 8.56% during the period 2017-2021.

The report, Global Influenza Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is potential opportunities for POL. Across the globe, there is no uniformity or support for the use of decentralized influenza testing in primary and outpatient care. These testing are more often performed in POL. The payers, regulators, and administrators need to highlight the importance of POL testing as the capabilities of portable influenza testing instruments are advancing technically.

According to the report, one of the major drivers for this market is increasing demand for POC diagnostics. The increasing demand for POC tests for diagnosis of influenza A and influenza B infections is expected to fuel the market growth. The POC tests have the potential to improve the management of both types of influenza diseases. These are much needed in resource-limited settings, where the access to quality and on-demand medical care is a challenge.

Key vendors

  • Alere
  • Becton Dickinson
  • bioMerieux
  • Quidel

Other prominent vendors

  • Autoimmune Technologies
  • Biocartis
  • EKF Diagnostics
  • Grifols
  • Meridian Bioscience
  • Response Biomedical
  • SA Scientific
  • Sekisui Medical

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by indication

PART 07: Market segmentation by product

PART 08: Market segmentation by end-users

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Key vendor analysis

For more information about this report visit http://www.researchandmarkets.com/research/88xkfc/global_influenza

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing